NMS-P118 |
Inhibitor of PARP1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PARP1 |
|
|
Inhibitor
100 nM - 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency: KD - PARP2: 1.39 uM, PARP3 (ARTD3): 0.69 uM, TNKS1 (PARP5a): >10 uM
Potency Assay Off-Target:
SPR binding assay
Selectivity Assessment Description:
In CYP inhibition assays, NMS-P118 had only moderate activity against two of eight CYP proteins ( ...
In Cell Selectivity Assessment
Potency: IC50 - SIRT1: >10 uM
Potency Assay Off-Target:
HeLa cell PAR assay. Also in cells, NMS-P118 potently inhibited proliferation of BRCA1-mutant MDA-MB ...
Potency Cellular
In Vitro
PARP1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
In Vivo Validations
Harlan nu/nu mouse, Sprague Dawley rat
Dose: 10 mg/kg
Route of delivery:
Intravenous, Oral
Plasma half life:
3.3 h (mouse, IV), 3.1 h (mouse, oral), 4.7 h (rat, IV), 3.9 h (rat, oral)
Systemic clearance:
19.3 mL/min/kg (mouse, IV); 10.8 (rat, IV)
Organ of interest (O):
xenograft
Target engagement assay:
In Caplan-1 xenograft, NMS-P118 inhibited PAR production in the tumor.
Reference: --
Chemical Information
| Molecular Formula | C20H24F3N3O2 |
| SMILEs | NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2 |
| InChI | InChI=1S/C20H24F3N3O2/c21-13-9-12-11-26(19(28)17(12)16(10-13)18(24)27)15-3-7-25(8-4-15)14-1-5-20(22,23)6-2-14/h9-10,14-15H,1-8,11H2,(H2,24,27) |
| Molecular weight | 395.18 Da |
| AlogP | 2.9227000000000016 |
| HBond acceptors | 5 |
| HBond donors | 2 |
| Atoms | 52 |
References
Publications
Cross References
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.